Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Axcel VI and the Currentum Group in connection with the acquisitions of Ingenjörsfirman Gösta Schelin, Ventilationshygien Stockholm and Pactor Luftbehandling
Mandate

Vinge advises Axcel VI and the Currentum Group in connection with the acquisitions of Ingenjörsfirman Gösta Schelin, Ventilationshygien Stockholm and Pactor Luftbehandling

March 31, 2021 Employment and Benefits M&A Real Estate and Construction

Vinge advises Axcel VI and the Currentum Group in connection with the acquisitions of Ingenjörsfirman Gösta Schelin Aktiebolag, Ventilationshygien Stockholm AB and Pactor Luftbehandling Aktiebolag.

The companies provide services within design, installation and service linked to indoor climate and are based in Stockholm. Together, the companies have a turnover of approximately SEK 250 million. The transaction is subject to customary regulatory approvals.

Vinge’s team consisted of partner Christina Kokko together with Karl Klackenberg, Hannah Kajlinger and Carl Fredrik Wachtmeister (M&A), Isak Willborg (Construction), Elin Broman (Employment) and Frida Ställborn (Real Estate).

Related

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

 Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025